Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human Kallikrein 6 Antikörper:
anti-Rat (Rattus) Kallikrein 6 Antikörper:
anti-Mouse (Murine) Kallikrein 6 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Monoclonal Kallikrein 6 Primary Antibody für ELISA, WB - ABIN519338
Lou, Si, Chen, Sun, Zhang, Niu, Hu: Correlation between KLK6 expression and the clinicopathological features of glioma. in Contemporary oncology (Pozna?, Poland) 2014
Mouse (Murine) Polyclonal Kallikrein 6 Primary Antibody für ELISA, WB - ABIN4328114
Iwata, Maruyama, Akagi, Hashikawa, Kanazawa, Tsuji, Nukina: Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies. in Human molecular genetics 2003
Results showed a significant downregulation of KLK6 (zeige KLK1 Antikörper) mRNA expression in breast cancer (BC) tissue sections compared to the non-cancerous component. The expression of KLK6 (zeige KLK1 Antikörper) is positively associated with tumor grade and is overexpressed in aggressive phenotypes such as TNBC.
KLK6 (zeige KLK1 Antikörper)-PAR2 (zeige F2RL1 Antikörper) expression is down-regulated and PAR1 (zeige MARK2 Antikörper) is up-regulated when DeltaNp63beta expression is decreased, leading to EMT (zeige ITK Antikörper) with enhancing migration and invasion through ERK (zeige EPHB2 Antikörper) signal reduction at the invasive front
KLK6 (zeige KLK1 Antikörper) may be the key protease involved in the proteolytic modification of PFK-M (zeige PFKM Antikörper).
Our data demonstrate for the first time increased levels of KLK6 (zeige KLK1 Antikörper) in mucosal melanomas of the head and neck
Induction of autophagic processes through KLK6 (zeige KLK1 Antikörper) expression may increase acquisition of resistance of gastric cancer cells to auranofin-induced autophagy.
Our data provide experimental evidence that KLK6 (zeige KLK1 Antikörper) controls metastasis formation in colon cancer via specific downstream network of miRNA-mRNA effectors.
Data show that kallikrein 6 (KLK6) expression is induced in mouse and human skin during chronic glucocorticoid treatment.
FST (zeige FST Antikörper) and KLK6 (zeige KLK1 Antikörper) may have significance in breast cancer detection
KLK6 (zeige KLK1 Antikörper) overexpression and likely its proteolytic activity is associated with alterations in downstream miRNAs and their targets, and these differ with the molecular subtypes of breast cancer.
Molecular models of peptides were built into the KLK6 (zeige KLK1 Antikörper) structure and the marked preference of the cut between the two R of the examined peptides was related to the extended conformation of the substrates
Kallikrein 6 (zeige KLK1 Antikörper) secreted by oligodendrocytes plays a critical role in the pathogenesis of experimental autoimmune encephalomyelitis.
Data show that kallikrein 6 (KLK6 (zeige KLK1 Antikörper)) expression is induced in mouse and human skin during chronic glucocorticoid treatment.
Klk6 (zeige KLK1 Antikörper) represents an important target for conditions in which pro-inflammatory responses play a critical role in disease development, including MS
KLK6 (zeige KLK1 Antikörper) protein from 129 mice showed reduced SDS (zeige SDS Antikörper)-PAGE mobility compared with that from C57BL/6 mice; recombinant KLK6 (zeige KLK1 Antikörper) protein from 129 mice had a higher optimum pH and >15 times higher hydrolytic enzymatic activity for several substrates than that from C57BL/6 mice. These results suggest that KLKs may contribute to the genetic basis of the differences between mouse strains.
these data point to a novel kallikrein 6 (zeige KLK1 Antikörper) -signaling axis in neurons that is mediated by PAR1 (zeige F2R Antikörper) and PAR2 (zeige F2RL1 Antikörper) and is positioned to contribute to neurodegeneration
These results indicate that KLK6 (zeige KLK1 Antikörper) plays a functional role in oligodendrocyte development and the expression of myelin proteins.
Neuropathological analysis following delivery of LV-Neurosin to alpha-syn tg mice resulted in reduced accumulation of alpha-syn and reversal of neurodegenerative alterations in wild type but not A53T alpha-syn tg mice
We have found an increase in the level of neurosin, a key negative regulator of SNCA in the Ts65Dn mouse model for Down syndrome
KLK6 (zeige KLK1 Antikörper) is positioned to serve as a molecular trigger of select physiological processes involved in the development of astrogliosis
Klk8 is involved in the proliferation and migration of keratinocytes through Klk6 (zeige KLK1 Antikörper) in the early stages of wound healing, and possibly in keratinocyte differentiation associated with the upregulation of PAR2 (zeige F2RL1 Antikörper) in the late stages of wound healing.
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. The encoded enzyme is regulated by steroid hormones. In tissue culture, the enzyme has been found to generate amyloidogenic fragments from the amyloid precursor protein, suggesting a potential for involvement in Alzheimer's disease. Multiple alternatively spliced transcript variants that encode different isoforms have been identified for this gene.
, protease M
, serine protease 18
, serine protease 9
, kallikrein 6 (neurosin)
, kallikrein 6 (neurosin, zyme)
, protease serine 9 (neurosin)
, protease, serine, 9
, brain serine protease
, kallikrein 29
, kallikrein 6
, myelencephalon-specific protease
, myofibril-bound protease
, protease, serine, 18